Literature DB >> 6500233

Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats.

K Imaida, S Fukushima, T Shirai, T Masui, T Ogiso, N Ito.   

Abstract

The promoting effects of butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and sodium L-ascorbate on two-stage carcinogenesis initiated with methylnitrosourea (MNU) in F344 male rats were investigated. Animals were given injections of MNU (20 mg/kg ip) twice a week for 4 weeks, and then basal diet containing 2% BHA, 1% BHT or 5% sodium L-ascorbate for the next 32 weeks. Administration of BHA, BHT or sodium L-ascorbate in the diet significantly increased the incidences per group and numbers per rat of papilloma and papillary or nodular hyperplasia of the urinary bladder, and BHA and BHT also increased the number of cancers per rat. Furthermore BHA significantly increased the incidences of cancer and papilloma in the forestomach of rats initiated with MNU, whereas treatment with BHA alone was associated with papilloma but no carcinoma development in the rat forestomach. The incidence of adenoma, but not adenocarcinoma, of the thyroid was significantly increased by treatment with MNU plus BHT. These results show that BHA, BHT and sodium L-ascorbate have promoting activities on urinary bladder carcinogenesis in rats initiated with MNU, and that BHA also has a promoting effect on forestomach carcinogenesis after initiation with MNU.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500233

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  13 in total

1.  DNA cleavage by metabolites of butylated hydroxytoluene.

Authors:  F Nagai; K Ushiyama; I Kano
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

2.  Identification of tumor promoters by their inhibitory effect on intercellular transfer of lucifer yellow.

Authors:  I V Budunova; L A Mittelman; G A Belitsky
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

3.  Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants.

Authors:  Y Kurata; S Fukushima; R Hasegawa; M Hirose; M Shibata; T Shirai; N Ito
Journal:  Jpn J Cancer Res       Date:  1990-08

4.  Comparison of reversibility of rat forestomach lesions induced by genotoxic and non-genotoxic carcinogens.

Authors:  M Kagawa; K Hakoi; A Yamamoto; M Futakuchi; M Hirose
Journal:  Jpn J Cancer Res       Date:  1993-11

5.  Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats.

Authors:  S Fukushima; A Hagiwara; M Hirose; S Yamaguchi; D Tiwawech; N Ito
Journal:  Jpn J Cancer Res       Date:  1991-06

6.  Hepatocellular tumorigenicity of butylated hydroxytoluene administered orally to B6C3F1 mice.

Authors:  K Inai; T Kobuke; S Nambu; T Takemoto; E Kou; H Nishina; M Fujihara; S Yonehara; S Suehiro; T Tsuya
Journal:  Jpn J Cancer Res       Date:  1988-01

7.  Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.

Authors:  S Ono; Y Kurata; Y Shichino; M Sano; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1992-09

8.  Dose dependence of 1-O-hexyl-2,3,5-trimethylhydroquinone promotion of forestomach carcinogenesis in rats pretreated with N-ethylnitrosourethane.

Authors:  Y Mizoguchi; M Hirose; T Yamaguchi; P Boonyaphiphat; T Miki; T Shirai
Journal:  Jpn J Cancer Res       Date:  1998-05

9.  Effects of phenobarbital and carbazole on carcinogenesis of the lung, thyroid, kidney, and bladder of rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.

Authors:  T Shirai; A Masuda; K Imaida; T Ogiso; N Ito
Journal:  Jpn J Cancer Res       Date:  1988-04

10.  Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats.

Authors:  A Hagiwara; H Tanaka; K Imaida; S Tamano; S Fukushima; N Ito
Journal:  Jpn J Cancer Res       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.